Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal Ruchika Sharma4 Sept 2025 12:13 PM ISTShanghai: Argo Biopharmaceutical Co., Ltd., a clinical-stage biotechnology company focused on developing next-generation siRNA therapeutics, has...
Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license Ruchika Sharma4 Sept 2025 10:30 AM ISTUnder the terms of the agreement, Novartis will receive an exclusive worldwide license to research, develop, manufacture, and commercialize ARO-SNCA.
Eli Lilly appoints Vivek Jha as Sr Director - Commercial Strategy, AI & Transformation within the Global Commercialization Capabilities, Innovation organization Ruchika Sharma3 Sept 2025 5:34 PM ISTEli Lilly and Company has appointed Vivek Jha as Leader (Senior Director) - Commercial Strategy, AI & Transformation within the Global...
Novartis Leqvio shows statistically significant, clinically meaningful early LDL-C goal achievement with less muscle pain Ruchika Sharma2 Sept 2025 12:25 PM ISTBasel: Novartis has announced positive results from V-DIFFERENCE, a Phase IV study evaluating Leqvio (inclisiran) compared to placebo, both...
Eris Lifesciences Slapped Rs 17 Crore GST Notice Over Novartis Zomelis Deal Farhat Nasim27 Aug 2025 10:00 AM ISTNew Delhi: Eris Lifesciences Limited has disclosed that it has received a show cause-cum-demand notice amounting to Rs16.84 crore from the Directorate...
Novartis ianalumab Phase III trial meets primary endpoint in immune thrombocytopenia Ruchika Sharma17 Aug 2025 2:00 PM ISTBasel: Novartis has announced positive top-line results from VAYHIT2, a Phase III trial evaluating ianalumab plus eltrombopag in patients with...
FDA Approves Inclisiran as First-Line LDL-C Treatment Without Statins Dr. Kamal Kant Kohli8 Aug 2025 9:15 AM ISTThe FDA has approved inclisiran (Leqvio) for first-line use in lowering LDL cholesterol, even without combining it with statins, according to...
Novartis eyes Avidity Biosciences in potential takeover: Report Ruchika Sharma7 Aug 2025 3:13 PM ISTSwiss pharmaceutical giant Novartis is exploring a potential acquisition of U.S. biotech firm Avidity Biosciences, according to a report by the...
Setback To Novartis: CDSCO Panel Rejects Lanalumab Phase III Trial Design Over Study Flaws Dr. Divya Colin4 Aug 2025 6:00 PM ISTNew Delhi: In a setback to Novartis, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has declined to...
Novartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial Proposal Parthika Patel3 Aug 2025 9:30 AM ISTNew Delhi: Novartis Healthcare Private Limited has been directed by the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
Novartis names Mukul Mehta as CFO Ruchika Sharma17 July 2025 12:46 PM ISTBasel: Novartis has announced the appointment of Mukul Mehta as the Chief Financial Officer (CFO) and a member of the Executive Committee of...
Novartis loses legal battle to block US Entresto generic until 2026 Ruchika Sharma12 July 2025 12:23 PM ISTWashington: In a significant legal setback for Novartis, a Delaware federal judge has said that Swiss pharmaceutical giant cannot stop...
